» Authors » Wendy A Gattis

Wendy A Gattis

Explore the profile of Wendy A Gattis including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 30
Citations 758
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Adams Jr K, Patterson J, Gattis W, OConnor C, Lee C, Schwartz T, et al.
J Am Coll Cardiol . 2005 Aug; 46(3):497-504. PMID: 16053964
Objectives: The purpose of this study was to investigate the relationship of serum digoxin concentration (SDC) and outcomes in women with heart failure (HF). Background: Controversy continues concerning the clinical...
2.
Felker G, Adams Jr K, Gattis W, OConnor C
J Am Coll Cardiol . 2004 Sep; 44(5):959-66. PMID: 15337204
Anemia has recently been recognized as an important comorbid condition and potentially novel therapeutic target in patients with heart failure (HF). Anemia is common in HF patients, with a prevalence...
3.
East M, Peterson E, Shaw L, Gattis W, OConnor C
Am Heart J . 2004 Jun; 148(1):151-6. PMID: 15215805
Background: More than half of all patients with congestive heart failure have preserved left ventricular systolic function. This is particularly common in African American patients, yet there have been few...
4.
Fonarow G, Abraham W, Albert N, Gattis W, Gheorghiade M, Greenberg B, et al.
Am Heart J . 2004 Jun; 148(1):43-51. PMID: 15215791
Heart failure (HF) affects >5 million patients in the United States, and its prevalence is increasing every year. Despite the compelling scientific evidence that angiotensin-converting enzyme inhibitors and beta-blockers reduce...
5.
Gattis W, OConnor C, Hasselblad V, Adams Jr K, Kobrin I, Gheorghiade M
Am J Cardiol . 2004 May; 93(11):1436-7, A10. PMID: 15165935
The relation of cardiac troponin-I (cTnI) to clinical outcomes was examined in patients with decompensated heart failure and concomitant acute coronary syndrome enrolled into the Randomized Intravenous TeZosentan 4 (RITZ-4)...
6.
Gattis W, OConnor C
Am J Cardiol . 2004 May; 93(9A):74B-6B. PMID: 15144943
The use of beta-blockers for the treatment of heart failure in the United States is inadequate, despite available data and current guidelines that support their use. The Initiation Management Predischarge:...
7.
Gattis W, OConnor C, Gallup D, Hasselblad V, Gheorghiade M
J Am Coll Cardiol . 2004 May; 43(9):1534-41. PMID: 15120808
Objectives: The Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy in Heart Failure (IMPACT-HF) trial was an investigator-initiated study to evaluate if predischarge carvedilol initiation in stabilized patients hospitalized...
8.
Gheorghiade M, Gattis W, OConnor C, Adams Jr K, Elkayam U, Barbagelata A, et al.
JAMA . 2004 Apr; 291(16):1963-71. PMID: 15113814
Context: Nearly 1 million hospitalizations for chronic heart failure occur yearly in the United States, with most related to worsening systemic congestion. Diuretic use, the mainstay therapy for congestion, is...
9.
Klein L, Gattis W, Borrello F, Wu E, OConnor C, Gheorghiade M
Am J Cardiol . 2004 Apr; 93(8A):44A-46A. PMID: 15094106
A considerable number of patients with reduced systolic function caused by primary or ischemic cardiomyopathy have viable and noncontractile myocardium. This may be related to numerous and perhaps overlapping factors,...
10.
Joynt K, Gattis W, Hasselblad V, Fuzaylov S, Serebruany V, Gurbel P, et al.
Am J Cardiol . 2004 Mar; 93(6):783-5. PMID: 15019895
C-reactive protein (CRP) levels were measured in a cohort of 96 outpatients with heart failure. Baseline angiotensin-converting enzyme inhibitor plus beta-blocker use were associated with lower levels of CRP; no...